These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 15184840

  • 1. Carvedilol: beta-blockade and beyond.
    Stroe AF, Gheorghiade M.
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S18-27. PubMed ID: 15184840
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD.
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [Abstract] [Full Text] [Related]

  • 6. Carvedilol: something else than a simple betablocker?
    Palazzuoli A, Calabria P, Verzuri MS, Auteri A.
    Eur Rev Med Pharmacol Sci; 2002 Jun; 6(6):115-26. PubMed ID: 12776805
    [Abstract] [Full Text] [Related]

  • 7. Beta-blockers in heart failure: potential of carvedilol.
    Fowler MB.
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S62-7. PubMed ID: 8098065
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K, Androne AS, Hudaihed A, Katz SD.
    Circulation; 2003 Aug 26; 108(8):971-6. PubMed ID: 12912816
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Practical considerations for switching beta-blockers in heart failure patients.
    Abraham WT, Iyengar S.
    Rev Cardiovasc Med; 2004 Aug 26; 5 Suppl 1():S36-44. PubMed ID: 15184837
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
    Remme WJ, Torp-Pedersen C, Cleland JG, Poole-Wilson PA, Metra M, Komajda M, Swedberg K, Di Lenarda A, Spark P, Scherhag A, Moullet C, Lukas MA.
    J Am Coll Cardiol; 2007 Mar 06; 49(9):963-71. PubMed ID: 17336720
    [Abstract] [Full Text] [Related]

  • 17. Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
    Remme WJ, Cleland JG, Erhardt L, Spark P, Torp-Pedersen C, Metra M, Komajda M, Moullet C, Lukas MA, Poole-Wilson P, Di Lenarda A, Swedberg K.
    Eur J Heart Fail; 2007 Nov 06; 9(11):1128-35. PubMed ID: 17716943
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Carvedilol in ischemic heart failure. Hibernating myocardium resuscitated].
    MMW Fortschr Med; 2003 Feb 20; 145(8):57. PubMed ID: 12661451
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.